Dr. Mitchell Schwartz, M.D

NPI: 1174594089
Total Payments
$2,458
2024 Payments
$942.52
Companies
24
Transactions
149
Medicare Patients
5,689
Medicare Billing
$677,755

Payment Breakdown by Category

Food & Beverage$2,314 (94.1%)
Education$124.35 (5.1%)
Other$20.00 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,314 144 94.1%
Education $124.35 4 5.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20.00 1 0.8%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $563.92 32 $0 (2024)
PFIZER INC. $492.52 31 $0 (2024)
Janssen Biotech, Inc. $456.86 31 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $193.10 11 $0 (2024)
Gilead Sciences, Inc. $124.74 9 $0 (2024)
FUJIFILM Healthcare Americas Corporation $92.20 1 $0 (2024)
Daiichi Sankyo Inc. $84.79 5 $0 (2024)
GENZYME CORPORATION $70.76 4 $0 (2024)
Takeda Pharmaceuticals America, Inc. $67.66 4 $0 (2017)
Celgene Corporation $43.72 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $942.52 53 ABBVIE INC. ($237.68)
2023 $399.91 25 PFIZER INC. ($134.77)
2022 $327.34 15 ABBVIE INC. ($139.59)
2021 $153.98 6 Janssen Biotech, Inc. ($127.65)
2020 $67.59 5 AbbVie Inc. ($38.77)
2019 $278.50 25 Janssen Biotech, Inc. ($119.43)
2018 $133.88 10 PFIZER INC. ($36.46)
2017 $154.62 10 Takeda Pharmaceuticals America, Inc. ($67.66)

All Payment Transactions

149 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/19/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $18.03 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/18/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $21.21 General
Category: INTERNAL MEDICINE
12/16/2024 ABBVIE INC. CREON (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $20.00 General
Category: ENDOCRINOLOGY
12/11/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $5.13 General
Category: IMMUNOLOGY
12/05/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $16.30 General
Category: Immunology
11/21/2024 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $20.05 General
Category: Iron Deficiency Anemia
11/19/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $9.50 General
Category: IMMUNOLOGY
11/14/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $17.34 General
Category: Immunology
11/13/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $15.20 General
Category: VIROLOGY
11/13/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $8.04 General
Category: IMMUNOLOGY
11/05/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.87 General
Category: IMMUNOLOGY
10/31/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.98 General
Category: IMMUNOLOGY
10/27/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $18.03 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/22/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $19.00 General
Category: IMMUNOLOGY
10/21/2024 Intra-Sana Laboratories RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG Food and Beverage In-kind items and services $14.53 General
Category: GALLSTONES
10/17/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $8.09 General
Category: IMMUNOLOGY
10/15/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $18.76 General
Category: Immunology
10/09/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.47 General
10/07/2024 ABBVIE INC. LINZESS (Drug), VIBERZI, CREON Education In-kind items and services $8.45 General
Category: GASTROENTEROLOGY
09/26/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.77 General
Category: IMMUNOLOGY
09/19/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $20.68 General
Category: INTERNAL MEDICINE
09/19/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $18.47 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/18/2024 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $19.64 General
Category: Iron Deficiency Anemia
09/10/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $14.81 General
Category: INTERNAL MEDICINE
09/09/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.88 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 1,313 1,443 $1.3M $167,482
2022 14 1,297 1,598 $1.3M $170,331
2021 14 1,489 1,765 $1.3M $180,319
2020 15 1,590 1,894 $1.2M $159,623
Total Patients
5,689
Total Services
6,700
Medicare Billing
$677,755
Procedure Codes
58

All Medicare Procedures & Services

58 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 230 231 $438,323 $51,879 11.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 310 407 $142,043 $42,314 29.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 173 179 $285,505 $15,167 5.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 182 208 $48,880 $13,861 28.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 91 91 $40,040 $12,289 30.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 45 45 $76,230 $8,823 11.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 83 83 $150,645 $6,621 4.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 73 73 $25,696 $5,009 19.5%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 25 25 $42,350 $4,616 10.9%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 15 15 $25,410 $1,978 7.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 13 13 $5,694 $1,443 25.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 33 33 $4,719 $1,387 29.4%
76981 Ultrasound scan of organ tissue for measuring elasticity Office 2023 11 11 $3,998 $1,036 25.9%
91065 Measurement of hydrogen in breath to test for stomach and bowel symptoms Office 2023 13 13 $3,446 $994.24 28.9%
82272 Stool analysis for blood, by peroxidase activity Office 2023 16 16 $240.00 $66.40 27.7%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 206 207 $392,783 $43,011 11.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 276 396 $138,204 $40,290 29.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 320 392 $92,120 $28,790 31.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 183 190 $303,050 $16,082 5.3%
91110 Imaging of digestive tract done from the inside of the digestive tract Office 2022 12 12 $26,400 $8,525 32.3%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 96 96 $174,240 $7,947 4.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 38 38 $16,720 $4,746 28.4%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 23 23 $38,962 $4,548 11.7%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 30 30 $50,820 $4,164 8.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 42 42 $14,784 $3,401 23.0%

About Dr. Mitchell Schwartz, M.D

Dr. Mitchell Schwartz, M.D is a Gastroenterology healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174594089.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Schwartz, M.D has received a total of $2,458 in payments from pharmaceutical and medical device companies, with $942.52 received in 2024. These payments were reported across 149 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,314).

As a Medicare-enrolled provider, Schwartz has provided services to 5,689 Medicare beneficiaries, totaling 6,700 services with total Medicare billing of $677,755. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Oakhurst, NJ
  • Active Since 01/30/2006
  • Last Updated 03/31/2016
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1174594089

Products in Payments

  • XELJANZ (Drug) $407.86
  • STELARA (Biological) $356.24
  • RINVOQ (Biological) $194.16
  • Entyvio (Biological) $102.47
  • ENTYVIO (Biological) $99.42
  • SKYRIZI (Biological) $94.10
  • FUJIFILM (Device) $92.20
  • DUPIXENT (Biological) $88.62
  • INJECTAFER (Drug) $84.79
  • VELSIPITY (Drug) $68.69
  • TREMFYA (Drug) $64.97
  • EOHILIA (Drug) $49.13
  • ZEPOSIA (Drug) $43.72
  • HUMIRA (Biological) $40.09
  • CREON (Drug) $36.90
  • Creon (Drug) $36.75
  • REMICADE (Biological) $35.65
  • XIFAXAN (Drug) $33.30
  • CIMZIA (Drug) $26.82
  • LINZESS (Drug) $21.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Oakhurst